MedicinePOM

Dupilumab

Dupilumab (Dupixent) is an injectable biologic for eczema, asthma and other allergic conditions.

Clinical information

Common uses

moderate-to-severe atopic dermatitis (eczema)
add-on treatment for eosinophilic or steroid-dependent asthma
chronic rhinosinusitis with nasal polyps
eosinophilic esophagitis, prurigo nodularis, COPD, chronic hives

Common side effects

injection site reactions
conjunctivitis and other eye inflammation
oral herpes and other herpes infections
raised eosinophil counts
joint pain

Cautions

stop if hypersensitivity reaction such as anaphylaxis occurs
report new or worsening eye symptoms promptly
treat worm (helminth) infections before starting
do not stop steroid medicines abruptly

Interactions

live vaccines — avoid

Pregnancy: no increased risk identified in available data — discuss with your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Dupixent (dupilumab) label, setid 595f437d-2729-40bb-9c62-c8ece1f82780 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Dupilumab	Parenteral ( Prefilled Pen )	400mg	—	POM